|
Sasha Bondar was appointed as Executive Vice President and Chief Business Officer in October 2007. Prior to that he served as Vice President, Strategy & Corporate Development, from April 2005 to September 2007. Mr. Bondar joined the Company in May 2003 as Executive Director, Business Development, from The Aurora Funds, a Research Triangle Park, North Carolina-based venture capital firm, where he was focused on investing in early stage life sciences companies. Prior to that, Mr. Bondar served in a variety of management roles, most recently as Associate Director, Corporate Business Development, at Incyte Genomics (now Incyte Corporation) in Palo Alto, California. In this position he structured and negotiated strategic partnerships with biotechnology companies and worked with Incyte's Executive Committee in defining corporate strategy and evaluating potential mergers & acquisitions. Prior to that he was a major contributor to the successful launch of Incyte's pharmacogenomics program, and served as Technical Advisor to the intellectual property group. Mr. Bondar holds a B.S. degree in Biotechnology Management from Menlo College and an M.B.A. from Duke University's Fuqua School of Business. | 